Thrombectomy Catheters Market Experiences a Huge Growth

 

Overview

Thrombectomy Catheters are used for peripheral vascular procedures. A decade ago, catheter-based blood clot removal was the standard of care for acute coronary revascularization. However, the practice rapidly declined following large-scale trials that showed no benefit. Now, thrombectomy is routinely performed for other cardiovascular conditions such as pulmonary embolism, deep vein thrombosis, and venous thromboembolism. These devices are now available for the treatment of thrombosis, pulmonary embolism, and acute stroke. Thrombectomy Catheters have different levels of force for different procedures. Some require continuous force, while others only require targeted force. Pulsed force is often necessary during the procedure. The basic syringe-based systems don't provide this versatility. They require repeated catheter attachment and stopcock manipulation, and they can only fill 30 mL at a time.

To Get Complete Industry Insights, Grab Sample PDF Copy Here: https://bit.ly/3Kgz7n8

Drivers

Rising incidences of thrombotic disorders in the elderly population, in parallel to the growing number of cardiac surgeries, are expected to propel the growth of the global thrombectomy catheters market over the forecast period. For instance, in April 2022, Penumbra, a healthcare firm, received a CE Mark for its Indigo Aspiration System with mechanical thrombectomy technologies to provide pulmonary embolism treatment.

Moreover, the growing prominence of mechanical thrombectomy for the treatment of stroke patients, combined with the accelerated approval pathway for novel medical devices, is expected to boost the growth of the global thrombectomy catheters market during the forecast period.

Restraints

The high cost of equipment and the scarcity of specialized professionals are expected to limit the growth of the global thrombectomy catheters market.

Opportunities

Rising demand for minimally invasive thrombectomy procedures amidst increasing spending on medical services is expected to provide lucrative growth opportunities for players in the global thrombectomy catheters market.

Regional Analysis

North America is expected to experience robust growth over the forecast period in the global thrombectomy catheters market. Increasing cases of stroke in geriatric patients and an accelerated approval pathway for novel products are driving the growth of the thrombectomy catheters market in this region.

The Asia Pacific region is expected to witness significant growth during the forecast period in the global thrombectomy catheters market. Rising expenditure on the healthcare sector and an increasing volume of cardiac patients are propelling the growth of the thrombectomy catheters market in this region.

Competitive Landscape

Major companies contributing to the global thrombectomy catheters market include Philips, Penumbra, Medtronic, Boston Scientific, Stryker Corporation, Johnson & Johnson, Teleflex, Terumo, and AngioDynamics.

Key Developments

• In April 2022, Surmodics, Inc., a leader in providing in-vitro diagnostic technologies, reported that its Pounce™ Thrombectomy System had received 100% success in 20 FIH (first-in-human) procedures.

• In March 2022, Medtronic initiated the PRAAN (Prospective registry for assessment of acute ischemic stroke patients treated with neurothrombectomy devices in India) program in India to collect real-world information related to the use of revascularization devices in stroke patients.